<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0010">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ghosh</surname>
    <given-names>A. K.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Brindisi</surname>
    <given-names>M.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shahabi</surname>
    <given-names>D.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chapman</surname>
    <given-names>M. E.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Mesecar</surname>
    <given-names>A. D.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Drug development and medicinal chemistry efforts toward SARS-coronavirus and Covid-19 therapeutics</article-title>. 
  <source>
   <italic toggle="yes">Chemmedchem</italic>
  </source>, (
  <issue>11</issue>), 
  <fpage>907</fpage>â€“
  <lpage>932</lpage>. 
  <pub-id pub-id-type="doi">10.1002/cmdc.202000223</pub-id>
  <pub-id pub-id-type="pmid">32324951</pub-id>
 </mixed-citation>
</ref>
